Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
Condition:   Meniere Disease Interventions:   Drug: OTO-104;   Drug: Placebo Sponsor:   Otonomy, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2018 Category: Research Source Type: clinical trials